Drug

AFATINIB DIMALEATE

Drug TypeAction TypeMechanism of ActionApprovedMax Trial PhaseMax GBM Phase
Small molecule INHIBITOR Receptor protein-tyrosine kinase erbB-2 inhibitor no 4 0